Healthcare provider profile · identity verified

Scott C Russell, MD

Internal Medicine · KANSAS CITY, MO · NPI 1316904295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	849	208
Amlodipine Besylate	Amlodipine Besylate	543	138
Rosuvastatin Calcium	Rosuvastatin Calcium	481	143
Levothyroxine Sodium	Levothyroxine Sodium	258	63
Metoprolol Succinate	Metoprolol Succinate	241	68
Metformin Hcl Er	Metformin Hcl	233	75
Losartan Potassium	Losartan Potassium	223	60
Omeprazole	Omeprazole	222	66
Olmesartan Medoxomil	Olmesartan Medoxomil	215	54
Gabapentin	Gabapentin	196	48
Ezetimibe	Ezetimibe	187	52
Hydrochlorothiazide	Hydrochlorothiazide	173	53
Alendronate Sodium	Alendronate Sodium	163	46
Jardiance	Empagliflozin	146	38
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	144	47
Tamsulosin Hcl	Tamsulosin Hcl	140	46
Lisinopril	Lisinopril	137	38
Carvedilol	Carvedilol	135	42
Montelukast Sodium	Montelukast Sodium	132	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	129	38
Simvastatin	Simvastatin	125	20
Trazodone Hcl	Trazodone Hcl	116	34
Alprazolam	Alprazolam	113	36
Lamotrigine	Lamotrigine	113	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	108	30
Fluticasone Propionate	Fluticasone Propionate	106	32
Spironolactone	Spironolactone	96	33
Pantoprazole Sodium	Pantoprazole Sodium	93	32
Escitalopram Oxalate	Escitalopram Oxalate	79	25
Esomeprazole Magnesium	Esomeprazole Magnesium	79	suppressed
Allopurinol	Allopurinol	72	19
Finasteride	Finasteride	72	22
Famotidine	Famotidine	70	18
Eliquis	Apixaban	68	15
Tizanidine Hcl	Tizanidine Hcl	68	25
Paroxetine Hcl	Paroxetine Hcl	58	16
Sertraline Hcl	Sertraline Hcl	58	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	18
Nitrofurantoin	Nitrofurantoin Macrocrystal	54	suppressed
Ozempic	Semaglutide	54	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	53	suppressed
Warfarin Sodium	Warfarin Sodium	53	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	51	51
Metformin Hcl	Metformin Hcl	51	17
Buspirone Hcl	Buspirone Hcl	49	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	18
Tramadol Hcl	Tramadol Hcl	47	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	14
Pravastatin Sodium	Pravastatin Sodium	44	14
Pioglitazone Hcl	Pioglitazone Hcl	43	11
Albuterol Sulfate Hfa	Albuterol Sulfate	42	21
Glimepiride	Glimepiride	41	15
Ipratropium Bromide	Ipratropium Bromide	40	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	14
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Potassium Chloride	Potassium Chloride	39	12
Xarelto	Rivaroxaban	38	suppressed
Bupropion Xl	Bupropion Hcl	37	14
Mirtazapine	Mirtazapine	37	suppressed
Mounjaro	Tirzepatide	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Meloxicam	Meloxicam	31	13
Clonidine Hcl	Clonidine Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	13
Valacyclovir	Valacyclovir Hcl	30	11
Celecoxib	Celecoxib	29	13
Chlorthalidone	Chlorthalidone	29	suppressed
Furosemide	Furosemide	29	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Indapamide	Indapamide	26	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	24	suppressed
Baclofen	Baclofen	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Valsartan	Valsartan	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Estradiol	Estradiol	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Linzess	Linaclotide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Atenolol	Atenolol	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	16	suppressed
Testosterone	Testosterone	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Temazepam	Temazepam	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Diazepam	Diazepam	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error